Purpose: Motivated by a prior successful randomized controlled trial showing that functional electrical stimulation (FES) therapy can restore voluntary arm and hand function in people with severe stroke, this study was designed to examine neuromuscular changes in the upper limb following intensive FES therapy, consisting of task-specific upper-limb movements with a combination of preprogrammed FES and manual assisted motion. Methods: The patient was a 22-year-old woman who had suffered a haemorrhagic stroke 2 years earlier. FES therapy was administered for 1 hour twice daily for 12 weeks, for a total of 108 treatment sessions. Results: While maximal voluntary contraction level of the upper-limb muscles did not show significant improvement, the ability to initiate and stop the muscle contraction voluntarily was regained in several upper-limb muscles (approx. 5%-15% of the maximum voluntary contraction of the same muscle in the less-affected arm). A reduction in arm spasticity was also observed, as indicated by the reduction of H-reflex in the wrist flexor muscle (82.1% to 45.0% in H max /M max ) and decreased Modified Ashworth Scale scores (from 3 to 2 for the hand and 4 to 3 for the arm). Coordination between shoulder and elbow joints during the circle-drawing test improved considerably over the course of FES therapy: the patient was unable to draw a circle at all at baseline but was able to do so proficiently at discharge. Conclusion: Improvements in upper-limb function observed in people with severe stroke following intensive FES therapy can be attributed to (a) regained ability to voluntarily contract muscles of the affected arm, (b) reduced spasticity and improved muscle tone in the same muscles, and (c) increased range of motion of all joints.
Neuromuscular electrical stimulation (NMES) is a useful therapeutic method to improve motor function. [1] [2] [3] [4] [5] [6] [7] [8] [9] Previous studies examining the use of NMES have demonstrated improvements in joint range of motion (ROM), [1] [2] [3] [4] force production of digits, 5 and magnitude of electromyographic (EMG) muscle activity, 6 as well as reduction of muscle tone. [7] [8] [9] While these studies have used NMES for single-joint exercise, some more recent research has focused on the effect of electrical stimulation on multi-joint upper-arm movement. 4, 5, [10] [11] [12] [13] Functional electrical stimulation (FES) therapy integrates electrical stimulation to peripheral sensory and motor nerves with repetitive functional movement of the paretic arm in people with hemiplegia or quadriplegia. [13] [14] [15] [16] In FES therapy, preprogrammed electrical stimulation and manual assisted joint motion by a therapist are used to help the patient improve voluntary arm and hand function. The combination of FES and manual assist allows the person to feel the desired muscle contractions as well as the associated arm motion. Simultaneously, sensory signals may be generated by the excitation of afferent pathways in the stimulated peripheral nerves. In theory, such neural activity promotes motor re-learning. 17 Recent studies using FES therapy have reported significantly better recovery of upper-limb function, specifically, in people with subacute stroke. [11] [12] [13] 15, 18 In particular, a randomized controlled trial (RCT) published by Thrasher and colleagues 15 showed an improvement of 24.5 points on the Upper Extremity Fugl-Meyer Assessment (maximum score ¼ 66 points; a difference of 10 points represents clinically relevant change). However, the neural mechanism underlying the improvement in sensorimotor function is still not fully understood, and it remains uncertain whether this therapy is effective for people with chronic stroke. 13, 19, 20 The purpose of our study, therefore, was to examine neuromuscular changes occurring in the upper limb (UL) of people with severe stroke over the course of intensive FES therapy. To eliminate any potential contributions of spontaneous recovery that may occur following stroke, we recruited a patient with chronic severe stroke whose stroke occurred 24 months before the study. The FES therapy consisted of a variety of task-specific multi-joint movements with the combination of manual assisted passive motion and preprogramed electrical stimulation. To capture the FES therapy-induced improvements in UL function, we performed the following assessments: 
METHODS

Case description and selection
The study participant was a 22-year-old woman who had experienced a haemorrhagic stroke in the right frontal parietal area, secondary to an anteriovenous malformation (AVM) bleed, 2 years (>24 months) before the study. According to practice guidelines endorsed by the American Heart Association and the American Stroke Association, she can be regarded as a chronic stroke patient (the guidelines define ''chronic stroke'' as >6 mo post stroke). 21 When the patient began in-patient rehabilitation, her motor recovery status, scored by CMSMR, was as follows: arm ¼ 1, hand ¼ 2, leg ¼ 2, and foot ¼ 2. After 4 months of rehabilitation, her CMSMR scores were arm ¼ 2, hand ¼ 2, leg ¼ 4, and foot ¼ 2. While her left leg showed good recovery, her left arm was not functional and had high muscle tone.
At the beginning of the FES therapy, the patient was walking independently in activities of daily living, with the help of a cane and ankle-foot orthosis, but rarely used her paretic arm for functional activities. Movement of her upper limb was characterized by a flexor synergy pattern. She had increased resistance to passive stretching in the distal flexor musculature. Using the two-point discrimination test, we confirmed that her tactile sensation was not severely impaired: she was able to discriminate two-point touch with her palm when points were about 3.5 cm apart. Before participating in the study, the patient was informed about the intervention and its potential risks and signed an informed consent form that was approved by the Review Board of the Toronto Rehabilitation Institute.
Functional electrical stimulation
To deliver the FES therapy, we used the Compex Motion electric stimulator (DJO International, Guildford, UK), a fully programmable FES system with standard self-adhesive surface stimulation electrodes that can be used to develop sophisticated custom-made neuroprostheses. 21 The following muscles were stimulated with surface stimulation electrodes (electrode locations are shown in Figure 1 ): anterior (aDel) and posterior deltoid (pDel), biceps (BB) and triceps brachialis (TB), extensor carpi radialis, extensor carpi ulnaris, flexor carpi radialis, and flexor carpi ulnaris. Muscles and nerves were stimu-lated using symmetrical biphasic current pulses, with a pulse duration of 250 microseconds and ramp-up and ramp-down times of 2 seconds. As in our previous studies, a constant stimulation frequency of 40 Hz was used. 13, 14 The therapist used a hand switch to trigger the stimulation in accordance with the patient's arm motion (see Figure 1a ).
FES therapy protocol
The protocol used in this study has been described elsewhere. [13] [14] [15] Briefly, the therapy consisted of preprogrammed coordinate muscular stimulation and manual assisted (externally generated) passive motion to establish physiologically correct movement. During each movement, the patient was asked to imagine the movements and to try to carry them out herself. The FES was delivered to shoulder and elbow extensor and flexor muscles while the patient (assisted by the therapist) performed six types of motions: (1) touch the nose, then extend the arm; (2) touch the contralateral shoulder, then extend the arm; (3) extend the arm forward in front of the body, then flex the arm; (4) abduct the shoulder with flexed biceps, then extend the elbow, then extend the fingers; (5) grasp and release large objects; and (6) grasp and release small objects. The stimulus pattern and target muscles are summarized in Table 1 and described in detail elsewhere. [13] [14] [15] FES therapy sessions took place twice daily for 1 hour per session. In people with stroke, neuromuscular recovery typically starts proximally, followed by recovery of the distal neuromuscular compartments. 15 The FES therapy therefore began by training shoulder and upper-arm muscles.
During the treatment, a therapist controlled/triggered the arm movements using a push button. During the movements, the physiotherapist guided the patient's arm and assisted her with the neuroprosthesis in performing the desired tasks. This assistance ensured that all movements were carried out in a physiologically correct way (i.e., neuroprosthesis-induced movements did not oppose natural joint movements and respected the anatomy of bone and soft-tissue composition). In the early stages of treatment, arm and hand tasks were performed by a combination of muscular stimulation and assistance from the therapist. As UL function improved improved, assistance was reduced to the necessary minimum. Typically, the stimulation protocols were adjusted weekly or every 2 weeks. The participant was asked to repeat the same arm task 10 times for each motion during a single treatment session.
Outcome measures
Clinical assessments CMSMR was used to evaluate motor paralysis of the arm and hand; Motricity Index tests 22 for the UL were also used to assess arm and hand function. The degree of spasticity in the affected UL was evaluated using the five-grade Modified Ashworth Scale (MAS).
H-reflex and M max assessments
To assess the excitability of the spinal motoneuron pool in the flexor carpi radialis (FCR) muscle, the Hoffman reflex (H-reflex) was elicited via stimulation of the left median nerve. A pair of anode and cathode electrodes was placed on the medial position of the cubital joint. A rectangular pulse (1 ms) was generated by a constant voltage stimulator (DPS-007; Dia Medical System Co., Japan), which was triggered once every 5 seconds. The magnitude of the motor (M) response and the H-reflex were measured as the peak-to-peak amplitude of each response. The maximum values of the H-reflex (H max ) and the motor response (M max ) were quantified. To evaluate the excitability of the spinal motoneuron pool, we calculated the H max /M max ratio.
Maximal voluntary contraction (MVC) test
Using a bipolar differential amplifier (Bortec AMT-8; Bortec Biomedical, Calgary, AB), we measured the EMG signals in the following paralyzed upper-arm muscles: aDel, pDel, BB, TB, FCR, extensor digitorum longus (EDL), and first distal interosseous (FDI). A pair of surface electrodes (BiPole; Bortec Biomedical, Calgary, AB) was placed along the muscle fibres over the belly of each muscle, with an inter-electrode (centre-to-centre) distance of 10 mm. The recorded EMG signals were amplified 500 times and digitized at a sampling rate of 1,000 Hz, over a period of 500 milliseconds before and 500 milliseconds after the onset of the movement.
Active ROM test
The patient was asked to move her arm (1) forward, (2) backward, (3) upward, (4) to the right side, and (5) to the left side as much as she could. During these movements, we used a three-dimensional tracking device (FASTRAK; Polhemus, Colchester, VT) to record the positions of the shoulder joint, elbow joint, wrist joint, and second joint of the index finger. The relative orientations and positions of each sensor were collected, at a sampling rate of 40 Hz, and stored on a PC.
Circle-drawing test
This test assessed the patient's ability to coordinate shoulder-and elbow-joint movements. Drawing a circle requires coordinating shoulder and elbow movements; for people with stroke, and specifically those who have spasm in their elbow joint, it is not easy to draw a wide and a properly shaped circle. As in the dynamic ROM test, we recorded the position of the shoulder, elbow, and wrist joints and the second joint of the index finger while the patient drew circles on a table. During the assessment, her movements were self-paced, and the task continued for 30 seconds.
Originally we planned to assess the patient using only clinical scales, H-reflex, and MVC measurements. During the first 6 weeks of training, however, she showed remarkable improvement in her shoulder and elbow motion, which prompted us to add dynamic ROM and circledrawing tests to further evaluate functional motion of the UL.
RESULTS
Clinical assessments
The patient successfully completed all training sessions and assessments. Following 12 weeks of the FES therapy, she was able to pick up a thin object and to touch her nose, which she could not do before the FES therapy sessions. Table 2 summarizes the changes in clinical assessment scores over the course of therapy. The CMSMR and Motricity Index showed no changes during the FES therapy period; MAS scores for the hand and wrist showed a reduction in spasticity over the course of training (wrist: 3 to 2; hand: 4 to 3).
H-reflex and M max
H-reflex, which reflects spinal motoneuron excitability, also showed remarkable reduction with training (see Figure 2 ). The size of the H-reflex was quite large at the beginning of therapy (82.1% M max ); as time passed, it decreased considerably, to 53.65% in week 6 and 45.04% in week 12. Maximal voluntary contraction Figure 3 shows the changes in MVC in the upper-arm muscles, obtained every 2 weeks. The MVC level of the affected arm was remarkably smaller than that of the unaffected arm. While some muscles showed no alteration in the MVC level, both FDI and TB muscles showed meaningful changes over the course of training, from no EMG activity at baseline to visible EMG activities as a result of the FES therapy. It is also worth noting that for many of the muscles that exhibited EMG activity from day 1, the patient had no voluntary control; following 5 or 6 weeks of FES therapy, however, she began to exhibit voluntary control over several stimulated muscles and was able to voluntarily activate and relax them. This was a dramatic change from her original condition, in that muscle tone decreased and the patient was now able to voluntary activate the muscles of interest, but the maximum EMG activity of these muscles did not change substantially.
Active ROM test Table 3 shows shoulder and elbow dynamic ROM. For the shoulder and elbow joints, ROM tended to be larger at week 12 than those measured at week 6. Figure 4 shows shoulder, elbow, wrist, and indexfinger trajectory during performance of the circle-drawing test. The absolute position of individual joints is represented in Figure 4a ; position of elbow, wrist, and index finger relative to the shoulder-joint coordinate (i.e., assuming that the reference coordinate frame is in the shoulder joint) are shown in Figure 4b . It is clear that as the FES therapy progressed, the patient went from not being able to draw a circle on day 1 to being able to do so during week 6 and, finally, being able to draw an even larger circle during week 12.
Circle-drawing test
DISCUSSION
The purpose of our study was to assess the effect of 12 weeks of intensive FES therapy on a person with chronic stroke. Although motor-capacity scores (i.e., CMSMR and MVC tests) showed no changes, MAS scores and the amplitude of the H-reflex were reduced as a result of the FES therapy. In addition, the kinematic results showed a profound improvement in the participant's ability to perform arm movements and to coordinate the shoulder and elbow joints. Furthermore, she acquired the ability to voluntarily contract and relax the muscles in her arm, although the strength of the muscle contraction did not improve substantially. Together, these changes effectively improved voluntary UL function so that our study participant, who was previously unable to use her stroke-affected arm, could voluntarily reach objects and grasp and manipulate smaller and light objects.
Traditionally, NMES has been used to increase the strength of voluntary muscle contractions in people with stroke. But recent applications of electrical stimulation are shifting the focus from muscle strengthening toward retraining the central nervous system and improving control of voluntary movements. In our study, FES therapy was used to retrain a person with severe chronic stroke to voluntarily perform coordinated multi-joint movements with her paretic arm, which previously was completely paralyzed. Since the stimulus intensity we used was approximately 2Â the motor threshold, one could not expect that the FES therapy would increase muscle strength. This assumption was confirmed by the results shown in Figure 3 ; that is, there were no consistent changes in MVC in the UL muscles. Therefore, the improvement observed should be attributed not to improved muscle strength but, rather, to retraining and plasticity of the central nervous system. Although motor score and MVC level showed no changes over the course of FES therapy, some muscles (i.e., TB and FDI) showed improved EMG activity as a result of FES therapy. Our results suggest that the contraction level induced by electrical stimulation was sufficient to reactivate the ''deactivated'' motor command to these muscles, since although these muscles showed no visible EMG activity at the beginning of the therapy, following the therapy the patient was able to voluntarily contract and relax them.
At the beginning of the FES therapy, the patient's UL had high muscle tone. The muscle tone of the wrist and elbow flexors decreased remarkably as a result of the FES therapy, as is clearly reflected in the results of the MAS (Table 2 ) and H-reflex (Figure 3 ). This result agrees with previous findings describing the effects of electrical stimulation in terms of reducing abnormally high muscle tone. [7] [8] [9] 12 The resting position and condition of the patient's arm and hand in her daily life were drastically changed over the course of training. At discharge from therapy, she could relax her arm and hand voluntarily and have them hang naturally at her side when not using the arm; when she needed to reach and grasp an object, her hand remained relaxed as her arm reached for the object, becoming active only when needed to grasp or release the object. This behaviour was strikingly different from the severe UL flexor synergy pattern observed when the study began. Our study used a preprogrammed stimulus pattern that was able to generate four UL movements/functions, similar to our previous RCT. 15 The temporal muscleactivation patterns induced by the FES were similar to those of an intact neuromuscular system performing the same task (i.e., the muscle activations were designed to clone actual natural movements). During the movements, therefore, the patient could feel when she was supposed to activate muscle contractions and how to sequence them to produce the desired movements. The fact that we observed marked changes in the H-reflex, and that several muscles that she was previously unable to voluntarily contract were under her voluntary control by the end of therapy, suggests that the functional improvements induced by FES therapy were due at least in part to changes occurring in the central nervous system. In other words, we believe that the intensive and repetitive yet diverse FES therapy promoted cortical reorganization. 13, 15, 23 We speculate, therefore, that the following mechanism is responsible for the changes observed in this and our previous studies: [13] [14] [15] if a person with hemiplegia who struggles to execute a task is assisted with FES to carry out that same task, he or she is effectively voluntarily generating the motor command (desire to move the arm, i.e., efferent motor command) while the FES is providing the afferent feedback (afferent sensory input) to indicate that the command was executed successfully. We hypothesize that by providing both motor command and sensory input to the central nervous system repetitively, for prolonged periods, this type of treatment facilitates functional reorganization and retraining of intact parts of the central nervous system and allows them to take over the functions of the damaged part. As voluntary function improves, the volitional-related sensory feedback from the stimulated muscles and arm 13, 15, 24 further contributes to this retraining process. 
CONCLUSION
The present study confirms the findings we previously obtained in an RCT, 15 as well as those of others, 12 that FES therapy can be used to improve voluntary UL function in people with chronic severe stroke. It also reinforces our prior finding that intensive FES therapy is effective even in cases of severe chronic UL impairment. This study is unique in having investigated on a weekly basis how the H-reflex and the EMGs of various muscles changed over time as a result of FES therapy. Our key finding is that muscles that were paralyzed before the study became active and were under the patient's voluntary control by the completion of therapy. The H-reflex also decreased almost 50% over the course of therapy, which suggests a significant reduction in muscle tone and/or spasticity as a result of this therapy. In future research, an RCT will be needed to ascertain the effect of FES therapy on the motor recovery of people with chronic severe stroke.
KEY MESSAGES What is already known on this topic
Functional electrical stimulation (FES) therapy consists of preprogrammed electrical stimulation and manual support of joint motion by a therapist, which together enable the patient to achieve functional arm motion. Recent randomized controlled trials of patients with severe subacute stroke, using identical FES therapy, reported significantly better recovery of UL function in the FES therapy group than in the control group, which received intensive conventional occupational therapy and physiotherapy to improve UL function following stroke. However, some important questions remain with respect to the FES therapy; for example, What is the neural mechanism underlying an improvement of the sensorimotor function? Will this therapy be equally effective for people with chronic stroke?
What this study adds
In this study, a person with chronic severe stroke received FES therapy for 60 minutes 2Â/day for 12 weeks and extensive neuromuscular assessments each week. As this level of therapy and the intensity and frequency of assessment is very demanding for the participant, only a single, carefully selected patient could participate in the study. Although our findings are derived from only one individual, they clearly show the efficacy of the FES therapy and provide insight into potential mechanisms of recovery of voluntary UL function observed in earlier randomized controlled trials with people with severe stroke.
